Accuracy of self-reported adherence to tuberculosis therapy among DOTS patients in Mumbai

0Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Purpose: To compared self-reported adherence to DOTS therapy with urine rifampicin metabolite levels and medical records among patients in Mumbai, India. Methods: Study subjects (N=538) were randomly selected from the DOTS centers in Mumbai, India. Self-reported adherence was ascertained by interviews; unannounced home visits were conducted, and urine samples were collected for rifampicin metabolite testing using the n-butanol test. Information from medical records was abstracted for documented receipt of drugs from the DOTS centers. Results: Agreement between self-reported adherence and urine tests was very poor (kappa, 0.08); and between self-reports and medical records was moderate (kappa, 0.47). Receipt of drugs did not ensure adherence. Based on urine n-butanol test, 75% of patients were adherent. Physical appearance of urine for rifampicin excretion with the n-butanol extraction method indicated a high positive predictive value (95%). Conclusion: We recommend incorporating urine tests for various drug metabolites periodically in the DOTS program to ensure treatment adherence. © Poracom Academic Publishers. All rights reserved.

Cite

CITATION STYLE

APA

Sathiakumar, N., Bagchi, S., Singh, D., Vijay, P. K., & Ambe, G. (2010). Accuracy of self-reported adherence to tuberculosis therapy among DOTS patients in Mumbai. International Journal of Health Research, 3(3), 133–137. https://doi.org/10.4314/ijhr.v3i3.70277

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free